Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Bone Marrow Transplantation (41)
Leukemia (13)
Oncogene (2)
Nature Reviews Microbiology (1)
Nature (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (39)
Special Features (12)
Reviews (4)
Correspondence (3)
Amendments and Corrections (1)

Subject Check one or more subjects to show results from those subjects only.

Biological techniques
Biomarkers
Biotechnology
Cancer
Diseases
Environmental social sciences
Genetics
Health care
Immunology
Medical research
Pathogenesis
Risk factors
Stem cells

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–50 of 59 results

Advanced filters: Author: A van Biezen Clear advanced filters

Reduction in the frequency of transplant-related complications in patients with chronic myeloid leukemia undergoing BMT preconditioned with a new, non-myeloablative drug combination

E Kelemen
T Masszi
K Pálóczi
Research21 Apr 1998
Bone Marrow Transplantation

Volume: 21, P: 747-749
A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes

E Wattel
E Solary
P Fenaux
Research16 Apr 1999
Leukemia

Volume: 13, P: 524-529
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison

Dietrich Wilhelm Beelen
Simona Iacobelli
Mohamad Mohty
ResearchOpen Access21 Feb 2024
Bone Marrow Transplantation

Volume: 59, P: 670-679
EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)

W. Wiktor-Jedrzejczak
J. Drozd-Sokolowska
P. Dreger
Research21 Jan 2019
Bone Marrow Transplantation

Volume: 54, P: 1391-1398
Ultra-fast deep-learned CNS tumour classification during surgery

Sturgeon is a pretrained neural network that uses incremental results from nanopore sequencing to rapidly classify central nervous system tumours and can be used to aid critical decision-making during surgery.

C. Vermeulen
M. Pagès-Gallego
J. de Ridder
ResearchOpen Access11 Oct 2023
Nature

Volume: 622, P: 842-849
Graft-versus-myeloma after withdrawal of immunosuppression following allogeneic peripheral stem cell transplantation

J Libura
T Hoffmann
A Gratwohl
Research05 Oct 1999
Bone Marrow Transplantation

Volume: 24, P: 925-927
Mechanisms of plant resistance to viruses

Jennifer L. M. Soosaar
Tessa M. Burch-Smith
Savithramma P. Dinesh-Kumar
Reviews10 Aug 2005
Nature Reviews Microbiology

Volume: 3, P: 789-798
Identification of novel molecular markers which correlate with HPV-induced tumor progression

Matthias Nees
Erwin van Wijngaarden
Matthias Dürst
Research02 Jun 1998
Oncogene

Volume: 16, P: 2447-2458
Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT survey

R Arnold
T de Witte
JF Apperley
Research18 Jun 1998
Bone Marrow Transplantation

Volume: 21, P: 1213-1216
Haploidentical family member transplants for patients with chronic myeloid leukaemia: a report of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

DE Speiser
J Hermans
JF Apperley
Research01 Jun 1997
Bone Marrow Transplantation

Volume: 19, P: 1197-1203
Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome

V Runde
T de Witte
J Apperley
Research05 Mar 1998
Bone Marrow Transplantation

Volume: 21, P: 255-261
Blood and marrow transplantation activity in Europe 1997

A Gratwohl
J Passweg
J Hermans
Special Features23 Jul 1999
Bone Marrow Transplantation

Volume: 24, P: 231-245
A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

H K Al-Ali
R Brand
T de Witte
Research05 Jul 2007
Leukemia

Volume: 21, P: 1945-1951
Blood and marrow transplantation activity in Europe 1996

A Gratwohl
J Passweg
J Hermans
Special Features13 Aug 1998
Bone Marrow Transplantation

Volume: 22, P: 227-240
The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation

M Stelljes
A van Biezen
T Ruutu
Research25 Aug 2008
Bone Marrow Transplantation

Volume: 42, P: 739-742
Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation

H W Auner
R Szydlo
N Kröger
Research27 May 2013
Bone Marrow Transplantation

Volume: 48, P: 1395-1400
Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium

W Wiktor-Jedrzejczak
C Dearden
P Dreger
Research25 Nov 2011
Leukemia

Volume: 26, P: 972-976
Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation

T Ruutu
A van Biezen
T de Witte
Research12 Mar 2012
Bone Marrow Transplantation

Volume: 47, P: 1459-1464
The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry

M Michallet
M Sobh
P Dreger
Research12 Aug 2010
Leukemia

Volume: 24, P: 1725-1731
Decrease of lethal infectious complications in the context of causes of death (COD) after hematopoietic cell transplantation: COD-2 and COD-1 study of the Infectious Diseases Working Party EBMT

Jan Styczynski
Gloria Tridello
Rafael de la Camara
Research06 May 2023
Bone Marrow Transplantation

Volume: 58, P: 881-892
Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis

P Dreger
R Brand
D Niederwieser
Research14 Apr 2005
Leukemia

Volume: 19, P: 1029-1033
Stem cell transplantation from identical twins in patients with myelodysplastic syndromes

N Kröger
R Brand
T de Witte
Research08 Nov 2004
Bone Marrow Transplantation

Volume: 35, P: 37-43
Isolated HLA-C mismatches in unrelated donor transplantation for CML

J-M Tiercy
J Passweg
E Roosnek
Research07 Jun 2004
Bone Marrow Transplantation

Volume: 34, P: 249-255
Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome

N Kröger
R Brand
T de Witte
Research21 Nov 2005
Bone Marrow Transplantation

Volume: 37, P: 183-189
Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings

N Kröger
T Zabelina
T de Witte
Research23 Jul 2012
Leukemia

Volume: 27, P: 604-609
Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation

G W Basak
L C de Wreede
T de Witte
Research26 Nov 2012
Bone Marrow Transplantation

Volume: 48, P: 837-842
Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis

M Stern
L C de Wreede
T Ruutu
Research30 Apr 2014
Leukemia

Volume: 28, P: 2235-2240
Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial

S Iacobelli
L C de Wreede
G Gahrton
Research26 Jan 2015
Bone Marrow Transplantation

Volume: 50, P: 505-510
Genotypically nonidentical related donors for transplantation of patients with myelodysplastic syndromes: comparison with unrelated donor transplantation and autologous stem cell transplantation

T de Witte
F Pikkemaat
J Apperley
Research29 Nov 2001
Leukemia

Volume: 15, P: 1878-1884
Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors

Jan Styczyński
Gloria Tridello
Alois Gratwohl
ResearchOpen Access27 Aug 2019
Bone Marrow Transplantation

Volume: 55, P: 126-136
The political challenges of deep decarbonisation: towards a more integrated agenda

Andrew Jordan
Irene Lorenzoni
Simon G. Schaub
ReviewsOpen Access18 Mar 2022
Climate Action

Volume: 1, P: 1-12
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation

M van Gelder
L C de Wreede
J Schetelig
Research12 Dec 2016
Bone Marrow Transplantation

Volume: 52, P: 372-380
Erratum: Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

M Robin
R Porcher
N Kroger
Amendments and Corrections05 Jul 2017
Bone Marrow Transplantation

Volume: 52, P: 1081
Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation

J Schetelig
L C de Wreede
N Kröger
Research23 Jan 2017
Bone Marrow Transplantation

Volume: 52, P: 552-560
MyD genes in negative growth control

Dan A Liebermann
Barbara Hoffman
Reviews12 Jan 1999
Oncogene

Volume: 17, P: 3319-3329
The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT

Jakob R. Passweg
Helen Baldomero
Anna Sureda
ResearchOpen Access12 Feb 2025
Bone Marrow Transplantation

Volume: 60, P: 519-528
How should corticosteroids be used in the treatment of acute GVHD

T Ruutu
J Hermans
JF Apperley
Correspondence10 Sept 1998
Bone Marrow Transplantation

Volume: 22, P: 614-615
Patient engagement in hematopoietic stem cell transplantation and cell therapy: a survey by the EBMT patient engagement task force & transplantation complications working party

Hélène Schoemans
Linda J. Burns
Nicolaus Kroeger
Research18 Jun 2024
Bone Marrow Transplantation

Volume: 59, P: 1286-1294
Monosomal karyotype predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemia

M van Gelder
L C de Wreede
N Kröger
Research16 Oct 2012
Leukemia

Volume: 27, P: 879-888
Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party

C Koenecke
D Heim
N Kröger
Correspondence25 Apr 2016
Bone Marrow Transplantation

Volume: 51, P: 1259-1261
The EBMT–ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis

T Ruutu
A Gratwohl
R F Duarte
Special Features28 Nov 2016
Bone Marrow Transplantation

Volume: 52, P: 357-362
Allogeneic hematopoietic SCT for patients with autoimmune diseases

T Daikeler
T Hügle
A Gratwohl
Research12 Jan 2009
Bone Marrow Transplantation

Volume: 44, P: 27-33
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party

C Scheid
L de Wreede
N Kröger
ResearchOpen Access11 Sept 2017
Bone Marrow Transplantation

Volume: 52, P: 1519-1525
Graft-versus-host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in chronic myeloid leukemia patients

T Mutis
R Brand
E Goulmy
Correspondence27 May 2010
Leukemia

Volume: 24, P: 1388-1392
Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMT

R Martino
L de Wreede
M Mohty
Research03 Dec 2012
Bone Marrow Transplantation

Volume: 48, P: 761-770
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

M Robin
R Porcher
N Kroger
Research07 Nov 2016
Bone Marrow Transplantation

Volume: 52, P: 209-215
Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party

M Sobh
M Michallet
N Kröger
Research27 Apr 2016
Leukemia

Volume: 30, P: 2047-2054
Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT

T Ruutu
L C de Wreede
N Kröger
Research14 Sept 2015
Bone Marrow Transplantation

Volume: 50, P: 1542-1550
Hematopoietic stem cell transplantation for hematological malignancies in Europe

A Gratwohl
H Baldomero
A Urbano-Ispizua
Research15 May 2003
Leukemia

Volume: 17, P: 941-959
Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning

P Dreger
R Brand
D Niederwieser
Reviews15 May 2003
Leukemia

Volume: 17, P: 841-848